Targeted Therapies and other Agents as First-Line Maintenance and Beyond: Particular Benefit in Pulmonary Adenocarcinoma Patients

Publisher： Bentham Science Publishers

E-ISSN： 1875-533x|18|11|1640-1650

ISSN： 0929-8673

Source： Current Medicinal Chemistry, Vol.18, Iss.11, 2011-04, pp. : 1640-1650

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Oral isotretinoin is first-line treatment in severe nodular acne, with other agents indicated as second-line or adjunctive therapy

By  

Drugs & Therapy Perspectives, Vol. 27, Iss. 8, 2011-08 ,pp. : 11-14

Adis International

Access to resources Recommend Favorite

Docetaxel: clinical benefit in first-line treatment for NSCLC

By  

Inpharma, Vol. 1, Iss. 1348, 2002-01 ,pp. : 15-16

Adis International

Access to resources Recommend Favorite

First-line erlotinib maintenance cost effective in Europe

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 633, 2011-01 ,pp. : 5-5

Adis International

Access to resources Recommend Favorite

Update on Drug Interactions With Phosphodiesterase-5 Inhibitors Prescribed as First-Line Therapy for Patients with Erectile Dysfunction or Pulmonary Hypertension

By  

Current Drug Metabolism, Vol. 14, Iss. 2, 2013-02 ,pp. : 265-269

Bentham Science Publishers

Access to resources Recommend Favorite

The Avoiding Cardiovascular events through COMbination therapy in Patients Living with Systolic Hypertension (ACCOMPLISH) trial: a comparison of first-line combination therapies

By Weder Alan B  

Expert Opinion on Pharmacotherapy, Vol. 6, Iss. 2, 2005-02 ,pp. : 275-281

Informa Healthcare

Access to resources Recommend Favorite